Canada Life’s Evolus EOLS Stock Holding History

Canada Life’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-7,749	Closed	-$48K	–	1888
2025 Q3	$48K	Hold	7,749	–	–	﹤0.01%	1819
2025 Q2	$72K	Hold	7,749	–	–	﹤0.01%	1802
2025 Q1	$93K	Hold	7,749	–	–	﹤0.01%	1789
2024 Q4	$85K	Hold	7,749	–	–	﹤0.01%	1838
2024 Q3	$126K	Hold	7,749	–	–	﹤0.01%	1829
2024 Q2	$84K	Buy	7,749 +6,018	+348%	+$74K	﹤0.01%	1910
2024 Q1	$24K	Hold	1,731	–	–	﹤0.01%	2068
2023 Q4	$18K	Hold	1,731	–	–	﹤0.01%	2121
2023 Q3	$16K	Hold	1,731	–	–	﹤0.01%	2163
2023 Q2	$13K	Hold	1,731	–	–	﹤0.01%	2222
2023 Q1	$15K	Hold	1,731	–	–	﹤0.01%	2255
2022 Q4	$13K	Hold	1,731	–	–	﹤0.01%	2312
2022 Q3	$14K	Hold	1,731	–	–	﹤0.01%	2306
2022 Q2	$20K	Buy	+1,731	New	+$20.4K	﹤0.01%	2263
2020 Q2	–	Sell	-510	Closed	-$2K	–	2772
2020 Q1	$2K	Hold	510	–	–	﹤0.01%	2634
2019 Q4	$6K	Buy	+510	New	+$7.19K	﹤0.01%	2598
2019 Q3	–	Sell	-2,884	Closed	-$42K	–	1468
2019 Q2	$42K	Buy	+2,884	New	+$57.2K	﹤0.01%	2484

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canada Life's EOLS Position: Q4 2025 in Review

Canada Life sold out of Evolus (EOLS) in Q4 2025, closing a stake of 7,749 shares — an estimated $48K sold.

Canada Life first reported a position in EOLS in Q2 2019 and held it in 17 quarters. The position peaked at $126K in Q3 2024. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

Canada Life reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
Canada Life sold 7,749 Evolus shares in Q4 2025, an estimated $48K.
Canada Life first reported a position in Evolus in Q2 2019 and held it in 17 quarters.
Canada Life's Evolus position peaked at $126K in Q3 2024.
169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Canada Life's 13F filing for Q4 2025, filed 13 Feb 2026.